Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aurobindo Pharma Ltd

NSE: AUROPHARMA · BSE: 524804 · Pharmaceuticals & Biotechnology · 63 announcements

Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →
Share price
₹1,682.00
Market cap
₹97,691 Cr
Revenue (annual)
₹33,653 Cr
Net profit (annual)
₹3,505 Cr
P/E (TTM)
24.8×Sector 47.4×
Promoter holding
51.88%+0.06% QoQ
FII holding
16.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:32 IST BSE
Annual Report

Aurobindo Pharma Annual Report

Aurobindo Pharma Limited has submitted its Integrated Annual Report for FY 2025-26, alongside the notice for its 39th Annual General Meeting.